Urologie nieuws
- Mangoceuticals begins efficacy studies on its patented respiratory illness prevention technology in collaboration with Vipragen Biosciences and IntraMont Technologies
- Toekenningen voor onderzoeken naar T-cellen en epigenetica, nut katheterwissel bij urineweginfectie en meer
- Pseudoephedrine for ejaculatory dysfunction after retroperitoneal lymph node dissection in testicular cancer
- Conservative interventions for female exercise?induced urinary incontinence: a systematic review
- Prostate cancer blood test equally effective across ethnic groups, study finds
- “There is a lot of shame that comes with this”: A qualitative study of patient experiences of isolation, embarrassment, and stigma associated with overactive bladder
- UK MHRA grants marketing authorization to Pierre Fabre's vibegron to treat overactive bladder syndrome
- Penile intraepithelial neoplasia incidence, clinical classification, microenvironment and implications for imiquimod treatment
- Prospective study of urinary incontinence recovery following endoscopic enucleation of the prostate
- Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective ‘ablate?and?resect’ study
- Online decision aid for patients with prostate cancer evaluated by 11?290 patients and 91 urologists in Germany
- Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations
- The SUB?urothelial DUrvalumab InjEction?1 (SUBDUE?1) trial: first?in?human trial in patients with bladder cancer
- Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer
- Prognostic impact of histological discordance between transurethral resection and radical cystectomy